Member Info for Danielm89

CEL now 90m mcap from 30-40m on MHRA news. 150% rise

They applied 22nd December and received it 14th march.

OCTP 12m mcap MHRA news due any minute.. they applied 16th Jan 100% would put them at 24m mcap and still a 50% discount to ipo at 5p

Using working days and using cel as a reference it’s very soon.

Looking forward to seeing details of this:

In particular, negotiations concerning a significant order for an integrated service contract have progressed but have not materialised in time for the end of this year. While there is the possibility that negotiations could be completed in the near term, the majority of the revenues would be recognisable in the financial year commencing 1 April 2023.

“This submission is a very significant milestone for both the Company and its shareholders, as OCTP advances from a pre-clinical stage pharmaceutical company to a clinical stage pharmaceutical company.“

Iv put the link for the telegram group on twitter.. just search #OCTP

OCTP60% of people who undergo Chemotherapy contract CPIN With no current solution MHRA approval any day, with clinical trials to complete early Q2 (points at April/May in RNAs)Game changer in the pain relief market happening hereAlternative pain relief to opioids Flagship products are inhaler based removing the need of toxic tabletsThe global market for CIPN alone was valued at US$1.61bn in 2020 and is forecast to reach US$2.37bn by the year 202711m mcap,5m cash This product gets licensed or sold imo with OCTP having another 400 patents available

CIZ telegram group going up on twitter again search #ciz, Great little group no negativity and some cracking research definitely worth a look

Cough cough Neil

· mAb supplier agreements extended to increase use case diversity
· Work initiated to extend use case to breast cancer

My thinking is it would make sense, save time and money to have them being optimised together.

Re july RNA

Cizzle Biotechnology, the UK based diagnostics developer, is pleased to provide an update on the Company's progress to develop antibodies for use in its proprietary early lung cancer tests, and to announce a new project that may extend the range of early-stage cancers that its technology can detect, with a focus initially on breast cancer.
Highlights

· Monoclonal antibody ("mAb") to CIZ1B now in assay optimisation
· mAb reporter protein developed and ready for test development
· mAb supplier agreements extended to increase use case diversity
· Work initiated to extend use case to breast cancer

Wondering if the assays for the lung and breast cancer tests are being developed and optimised at the same time.

“In parallel, new projects have been initiated to evaluate the use of CIZ1B for the detection of other cancers, which has led to an initial focus on breast cancer, which could widen the utility of this important cancer biomarker.”

Now this would very good, two life changing assets potentially ready for US rollout after validation… what’s people’s thoughts? Am I seeing something that isn’t there or missing a step.

#CIZ interview key points:

1. Funded beyond 2024 once conduit completes #Nasdaq merger

2. Test is 95% effective and can detect other cancers

3. Actively seeking partnerships with “big biotech” for EU & UK

4. Assay optimisation due any day

5. Directors in a closed period due to inside information

6. Companion test and a new “monitor” test being explored

7. Directors look to active warrants at 15p and 20p in the near future

8. US rollout will be quick

I’ll re post on twitter, lse ban you for sharing on here. Search #ciz

The difference is we are above the 200 ma now for the first time ever old moot, so traders have brought added liquidity.

The warrants at 15p and 20p are a good sign you hopefully will. Along with “hardmans” claiming it was a 78% discount to its peers at 21m mcap.

Absolutely fine and completely understood. There’s over 100 of us now and we will have to appreciate your research from afar. You normally create quite a buzz when your in “the zone”.

Twitter sorry

It’s up, search #ciz on telegram

In fact anyone wanting to join the ciz telegram group I’ll put it up on twitter tomorrow for a few hours. Just search #ciz

Neil on behalf of the ciz telegram group… join us.

Choosing… fking auto correct the big nonce

The backlog of news, stockbox interview and biomarkers conference are more than enough to see us leave 2p behind us.

Lung diagnostic

Breast diagnostic

Companion test

Conduit

Chiding of manufacturer

Any other….

I’ll also add that stage 2 and 3 work in tandem as stage 2 is down to the JVs. Very exciting times. We could have a bonafide, operational and distributional product in a few months.